CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ ...
New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic research WALTHAM, Mass., October 15, ...
Thermo Fisher Scientific (TMO) just posted third-quarter results that came in ahead of expectations, showing healthy revenue ...
The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more clinical trials.
Join us for an insightful webinar on the use of polygenic risk scores (PRS) for cardiovascular disease (CVD). The analysis of genetic variation across large populations plays a crucial role in ...
Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback